RecruitingPhase 2NCT04041713
A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome
Sponsor
Holland Bloorview Kids Rehabilitation Hospital
Enrollment
35 participants
Start Date
Aug 24, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
This study will examine the potential efficacy and safety of Rett-T for core motor deficits of Rett syndrome, and will explore biological markers of safety and treatment response.
Eligibility
Sex: FEMALEMin Age: 2 YearsMax Age: 21 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying Placebo and a drug called Rett-T for people with rett syndrome. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 2 Years to 21 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGRett-T
antioxidant cocktail
OTHERPlacebo
Placebo
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04041713
Related Trials
A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome
NCT07503444
Rett REVOLUTION Trial: An Exploratory Evaluation of the Safety and Efficacy of Vorinostat in Rett Syndrome
NCT071500131 location
Rett Syndrome Registry
NCT0543234919 locations
Cognitive Function in Rett Syndrome During Trofinetide Treatment
NCT067058161 location
Safety and Preliminary Efficacy of TSHA-102 Gene Therapy in Pediatric Females Aged >2 to <4 Years With Rett Syndrome
NCT074805641 location